Development of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR- or CD46-positive cells

Journal of Gene Medicine

Volumn 15, Issue 1, 2013, Pages 1-11

  Janssen, Josephine M ^a   Liu, Jin ^a   Skokan, Jaroslav ^a   Gonçalves, Manuel A F V ^a   De Vries, Antoine A F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

AdEasy; Adenoviral vector; CAR; CD46; Fiber; Second generation

Indexed keywords

ADENOVIRUS VECTOR; MEMBRANE COFACTOR PROTEIN;

ADEASY SYSTEM; ARTICLE; BACTERIAL STRAIN; CELL TYPE; CHIMERA; ESCHERICHIA COLI; GENE DELETION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MUSCLE CELL; PRIORITY JOURNAL; TROPISM; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRUSES, HUMAN; ANTIGENS, CD46; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CELL LINE; CLONING, MOLECULAR; ENTEROVIRUS; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; GENETIC VECTORS; HELA CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA; TRANSDUCTION, GENETIC; VIRAL TROPISM;

EID: 84873050359     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.2687     Document Type: Article

References (37)

1. Volpers C, Kochanek S. Adenoviral vectors for gene transfer and therapy. J Gene Med 2004; 6(Suppl 1): S164-S171.
2. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
3. Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003; 9: 1408-1412.
4. Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G, Arnberg N. Adenovirus type 11 uses CD46 as a cellular receptor. J Virol 2003; 77: 9183-9191.
5. Wang H, Li ZY, Liu Y, et al. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med 2011; 17: 96-104.
6. Short JJ, Vasu C, Holterman MJ, Curiel DT, Pereboev A. Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors. Virus Res 2006; 122: 144-153.
7. Tuve S, Wang H, Jacobs JD, Yumul RC, Smith DF, Lieber A. Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathog 2008; 4: e1000189.
8. Gonçalves MA, de Vries AA. Adenovirus: from foe to friend. Rev Med Virol 2006; 16: 167-186.
9. Arnberg N. Adenovirus receptors: implications for targeting of viral vectors. Trends Pharmacol Sci 2012; 33: 442-448.
10. He T-C, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
11. Luo J, Deng ZL, Luo X, et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2007; 2: 1236-1247.
12. Imperiale MJ, Kao HT, Feldman LT, Nevins JR, Strickland S. Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity. Mol Cell Biol 1984; 4: 867-874.
13. Silva AC, Peixoto C, Lucas T, et al. Adenovirus vector production and purification. Curr Gene Ther 2010; 10: 437-455.
14. Havenga MJ, Holterman L, Melis I, et al. Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity. Biotechnol Bioeng 2008; 100: 273-283.
15. Shayakhmetov DM, Papayannopoulou T, Stamatoyannopoulos G, Lieber A. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J Virol 2000; 74: 2567-2583.
16. Knaän-Shanzer S, Van Der Velde I, Havenga MJ, Lemckert AA, de Vries AA, Valerio D. Highly efficient targeted transduction of undifferentiated human haematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B. Hum Gene Ther 2001; 12: 1989-2005.
17. Knaän-Shanzer S, van de Watering MJ, van der Velde I, Gonçalves MA, Valerio D, de Vries AA. Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells. Stem Cells 2005; 23: 1598-1607.
18. Gonçalves MA, de Vries AA, Holkers M, et al. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. Hum Mol Genet 2006; 15: 213-221.
19. Gonçalves MA, Holkers M, Cudré-Mauroux C, et al. Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells. Mol Ther 2006; 13: 976-986.
20. Nilsson M, Ljungberg J, Richter J, et al. Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant haematopoietic cells. J Gene Med 2004; 6: 631-641.
21. Yu L, Takenobu H, Shimozato O, et al. Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells. Oncol Rep 2005; 14: 831-835.
22. Tuve S, Wang H, Ware C, et al. A new group B adenovirus receptor is expressed at high levels on human stem and tumour cells. J Virol 2006; 80: 12109-12120.
23. Hoffmann D, Meyer B, Wildner O. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses. J Gene Med 2007; 9: 764-778.
24. Wang G, Li G, Liu H, et al. E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies. J Gene Med 2009; 11: 477-485.
25. Lie-A-Ling M, Bakker CT, Wesseling JG, et al. AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle. Gene Ther 2005; 12: 1347-1352.
26. Fallaux FJ, Bout A, van der Velde I, et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 1998; 9: 1909-1917.
27. Cudré-Mauroux C, Occhiodoro T, König S, Salmon P, Bernheim L, Trono D. Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a Duchenne myoblast cell line with long-term genotypic and phenotypic stability. Hum Gene Ther 2003; 14: 1525-1533.
28. Gonçalves MA, Swildens J, Holkers M, et al. Genetic complementation of human muscle cells via directed stem cell fusion. Mol Ther 2008; 16: 741-748.
29. Gonçalves MA, Janssen JM, Nguyen QG, et al. Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes. Mol Ther 2011; 19: 1331-1341.
30. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual (2nd edn). Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989.
31. Havenga MJ, Lemckert AA, Grimbergen JM, et al. Improved adenovirus vectors for infection of cardiovascular tissues. J Virol 2001; 75: 3335-3342.
32. Gonçalves MA, Pau MG, de Vries AA, et al. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors. Virology 2001; 288: 236-246.
33. Murakami P, McCaman MT. Quantification of adenovirus DNA and virus particles with the PicoGreen fluorescent Dye. Anal Biochem 1999; 274: 283-288.
34. Gonçalves MA, Holkers M, van Nierop GP, et al. Targeted chromosomal insertion of large DNA into the human genome by a fiber-modified high-capacity adenovirus-based vector system. PLoS One 2008; 3: e3084.
35. Caravokyri C, Leppard KN. Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5. J Virol 1995; 69: 6627-6633.
36. Takebe Y, Seiki M, Fujisawa J, et al. SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long-terminal repeat. Mol Cell Biol 1998; 8: 466-472.
37. San Martín C. Latest insights on adenovirus structure and assembly. Viruses 2012; 4: 847-877.